Craniopharyngioma: all 66 studies
Page 1 of 1. Open to participants first (19), then studies with results posted, then the rest; newest registration first within each.
- SEMAFORCRANIO : Multicenter, Double-blind, Parallel, Randomized Controlled Trial of the Efficacy of Semaglutide in Hypothalamic Obesity Secondary to Craniopharyngioma in Children Aged 12 to 17 YearsNot yet recruitingNCT07845994Phase 3
- A Comparative Study Evaluating the Impact of Intensive Dietary Care on Weight Change and Biological Parameters in Patients Who Underwent Surgery for Craniopharyngioma During the First Postoperative YearNot yet recruitingNCT07835165Not applicable
- Randomized Controlled Clinical Study on the Prophylactic Intraoperative Use of Desmopressin in Complex Sellar Region TumorsEnrolling by invitationNCT07712328Phase 4
- AI-Assisted MRI Molecular Subtyping in Pediatric Brain TumorsNot yet recruitingNCT07703605
- Clinical Trial of an Anti-Fog Drainage Device for Endoscopic Endonasal Sellar Region Tumor SurgeryRecruitingNCT07316101Not applicable
- Food Preferences and CraniopharyngiomasNot yet recruitingNCT07301554
- ImmunoPET Targeting Trophoblast Cell-surface Antigen 2 (Trop-2) in Craniopharyngioma PatientsRecruitingNCT07177482Not applicable
- Safety and Efficacy of Anlotinib in the Treatment of Recurrent CraniopharyngiomaRecruitingNCT06970145Phase 1/2
- The Impact of Endoscopic Endonasal Skull Base Surgery on OlfactionRecruitingNCT06874426
- Craniopharyngioma and PregnanciesRecruitingNCT06801756
- The Effect of GLP-1 Agonist in Patients With Hypothalamic Obesity: Prospective, Pilot StudyRecruitingNCT06217848Early Phase 1
- FOG-001 in Locally Advanced or Metastatic Solid TumorsRecruitingNCT05919264Phase 1/2
- Treatment of BRAF ( B-Rapidly Accelerated Fibrosarcoma) Mutated Papillary CraniopharyngiomaRecruitingNCT05525273Phase 2
- Tovorafenib for Treatment of Craniopharyngioma in Children and Young AdultsRecruitingNCT05465174Phase 2
- MEKTOVI® for the Treatment of Pediatric Adamantinomatous CraniopharyngiomaRecruitingNCT05286788Phase 2
- ACTEMRA® for the Treatment of Pediatric Adamantinomatous CraniopharyngiomaRecruitingNCT05233397Phase 2
- Proton Therapy Research Infrastructure- ProTRAIT- Neuro-oncologyRecruitingNCT04648462
- Multicenter Registry for Patients With Childhood.Onset Craniopharyngioma, Xanthogranuloma, Cysts of Rathke's Pouch, Meningioma, Pituitary Adenoma, Arachnoid CystsRecruitingNCT04158284
- Prospective Pilot Study Identifying Clinically Relevant Biological Targets for Medical TherapyEnrolling by invitationNCT03610906
- Fluorescence Detection of Adult Primary Central Nervous System Tumors With Tozuleristide and the Canvas SystemCompletedNCT04743310Phase 2Results posted
- Vemurafenib and Cobimetinib in Treating Patients With BRAF V600E Mutation Positive CraniopharyngiomaActive, not recruitingNCT03224767Phase 2Results posted
- Memantine for Prevention of Cognitive Late Effects in Pediatric Patients Receiving Cranial Radiation Therapy for Localized Brain TumorsCompletedNCT03194906Phase 2Results posted
- Intranasal Oxytocin in Hypothalamic ObesityCompletedNCT02849743Phase 2Results posted
- Molecular-Guided Therapy for Childhood CancerCompletedNCT02162732Not applicableResults posted
- Peginterferon Alfa-2b in Younger Patients With Craniopharyngioma That is Recurrent or Cannot Be Removed By SurgeryTerminatedNCT01964300Phase 2Results posted
- Weight Loss Study for Patients With Obesity Due to Craniopharyngioma or Other Brain TumorCompletedNCT01484873Phase 2Results posted
- China Treatment Trial for Tumor in Sellar Region With Unruptured Intracranial AneurysmActive, not recruitingNCT07809178
- Hypothalamic-Stratified Nursing Pathway for Pediatric CraniopharyngiomaCompletedNCT07342686
- Efficacy and Safety of Phentermine/Topiramate in Youth With Hypothalamic ObesityActive, not recruitingNCT06299891Phase 2
- Craniopharyngioma With Tumoral HemorrhageCompletedNCT04937335
- Long-Term Longitudinal QoL in Patients Undergoing EEAActive, not recruitingNCT04087902
- Tocilizumab in Children With ACPActive, not recruitingNCT03970226Early Phase 1
- Neuromodulation for Hypothalamic ObesityWithdrawnNCT03708913Not applicable
- Examination of Sleep and Family Functioning in Pediatric Craniopharyngioma PatientsCompletedNCT03330080
- Social Participation After Childhood CraniopharyngiomaCompletedNCT03139526
- Efficacy and Safety of Exenatide in the Treatment of Hypothalamic Obesity After Craniopharyngioma TherapyCompletedNCT02860923Phase 3
- Management of Pediatric Craniopharyngioma by a Combination of Partial Surgical Resection, and Protontherapy (Craniopharyngioma)CompletedNCT02842723Phase 2
- A Phase II Trial of Intensity-Modulated Proton Therapy for Incompletely Resected Craniopharyngioma and Observation for Craniopharyngioma After Radical ResectionActive, not recruitingNCT02792582Phase 2
- Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain TumorsWithdrawnNCT02194452Not applicable
- Effect of Perioperative Glucocorticoid Replacement on Prognosis of Surgical Patients With Sellar LesionsStatus unknownNCT02190994Phase 4
- An Efficacy, Safety, and Pharmacokinetics Study of Beloranib in Obese Subjects With Hypothalamic InjuryCompletedNCT02063295Phase 2
- Weight Gain in Surgically Treated Adult-onset CraniopharyngiomaCompletedNCT01968603
- Sleep Wake and Melatonin Pattern in CraniopharyngiomaCompletedNCT01881854
- A Phase II Trial of Limited Surgery and Proton Therapy for Craniopharyngioma or Observation After Radical ResectionActive, not recruitingNCT01419067Phase 2
- Prospective Study of Children and Adolescents With CraniopharyngiomaCompletedNCT01272622Not applicable
- 1.5T Intraoperative MR Imaging in CraniopharyngiomasCompletedNCT01206543Not applicable
- RO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant GliomaCompletedNCT01119599Phase 1
- Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell LeukemiaTerminatedNCT01088763Phase 1
- Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord TumorsCompletedNCT01076530Phase 1
- Vorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Central Nervous System Tumors and LymphomaCompletedNCT00994500Phase 1
- Tumor Classification and Its Application in Surgical Treatment of CraniopharyngiomaStatus unknownNCT00949156
- ABT-888 and Temozolomide in Treating Young Patients With Recurrent or Refractory CNS TumorsCompletedNCT00946335Phase 1
- Collecting and Storing Blood and Brain Tumor Tissue Samples From Children With Brain TumorsCompletedNCT00919750
- Hypothalamic Obesity Following Craniopharyngioma Surgery: A Pilot Trial of Combined Metformin and Diazoxide TherapyCompletedNCT00892073Phase 2
- Methionine PET/CT Studies In Patients With CancerActive, not recruitingNCT00840047Phase 2
- SCRT Versus Conventional RT in Children and Young Adults With Low Grade and Benign Brain TumorsStatus unknownNCT00517959Phase 3
- Ispinesib in Treating Young Patients With Relapsed or Refractory Solid Tumors or LymphomaCompletedNCT00363272Phase 1
- Effect of Diazoxide on the Obesity Secondary to Hypothalamic-pituitary LesionsCompletedNCT00306683Phase 3
- Observation of Young Patients Who Are Undergoing Surgery for CraniopharyngiomaCompletedNCT00258453Not applicable
- Positron Emission Tomography Using Fluorine F 18 EF5 to Find Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Newly Diagnosed Brain TumorsTerminatedNCT00110032Phase 1
- Lenalidomide in Treating Young Patients With Recurrent, Progressive, or Refractory CNS TumorsCompletedNCT00100880Phase 1
- Cilengitide in Treating Children With Refractory Primary Brain TumorsCompletedNCT00063973Phase 1
- FR901228 in Treating Children With Refractory or Recurrent Solid Tumors or LeukemiaCompletedNCT00053963Phase 1
- Temozolomide and O6-Benzylguanine in Treating Children With Recurrent Brain TumorsCompletedNCT00052780Phase 1
- Stereotactic Radiosurgery in Treating Patients With Brain TumorsCompletedNCT00019578Phase 1
- Irinotecan in Treating Children With Refractory Solid TumorsCompletedNCT00004078Phase 2